c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
about
Anti-pancreatic cancer deliverables from sea: first-hand evidence on the efficacy, molecular targets and mode of action for multifarious polyphenols from five different brown-algaeLow-grade slightly elevated and polypoid colorectal adenomas display differential β-catenin-TCF/LEF activity, c-Myc, and cyclin D1 expression.Pseudogenes as weaknesses of ACTB (Actb) and GAPDH (Gapdh) used as reference genes in reverse transcription and polymerase chain reactionsReactive oxygen species-mediated apoptosis contributes to chemosensitization effect of saikosaponins on cisplatin-induced cytotoxicity in cancer cells.Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancer.Complex alternative splicing of the smarca2 gene suggests the importance of smarca2-B variantsTwo RNAs or DNAs May Artificially Fuse Together at a Short Homologous Sequence (SHS) during Reverse Transcription or Polymerase Chain Reactions, and Thus Reporting an SHS-Containing Chimeric RNA Requires Extra Caution.Basic anatomy and tumor biology of the RPS6KA6 gene that encodes the p90 ribosomal S6 kinase-4.Delivery of intracellular-acting biologics in pro-apoptotic therapies.Cyclin D1 overexpression increases susceptibility to 4-nitroquinoline-1-oxide-induced dysplasia and neoplasia in murine squamous oral epitheliumCyclin-dependent kinase 4 may be expressed as multiple proteins and have functions that are independent of binding to CCND and RB and occur at the S and G 2/M phases of the cell cycle.Antitumor activity of the c-Myc inhibitor KSI-3716 in gemcitabine-resistant bladder cancer.Reviewing once more the c-myc and Ras collaboration: converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology.c-Myc induction of programmed cell death may contribute to carcinogenesis: a perspective inspired by several concepts of chemical carcinogenesis.Poor prognosis in cholangiocarcinoma patients with low FBXW7 expression is improved by chemotherapy.C-Myc participates in β-catenin-mediated drug resistance in A549/DDP lung adenocarcinoma cells.Splicing of mouse p53 pre-mRNA does not always follow the "first come, first served" principle and may be influenced by cisplatin treatment and serum starvation.Nicotine-induced survival signaling in lung cancer cells is dependent on their p53 status while its down-regulation by curcumin is independentCyclin D1 inhibits whereas c-Myc enhances the cytotoxicity of cisplatin in mouse pancreatic cancer cells via regulation of several members of the NF-κB and Bcl-2 families.Identification of the cyclin D1b mRNA variant in mouse.Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cellsNiclosamide enhances the cytotoxic effect of cisplatin in cisplatin-resistant human lung cancer cells via suppression of lung resistance-related protein and c-myc.Modelling the structure of a ceRNA-theoretical, bipartite microRNA-mRNA interaction network regulating intestinal epithelial cellular pathways using R programming.
P2860
Q28486199-7944E6AE-A623-4C17-9A3E-8862AC71496AQ33651968-6C537978-B168-404A-8F15-E61EDD8B448BQ34395392-F61773D1-108F-4558-B86B-C75F199BBBE8Q34426587-4F565A7D-F047-4E66-8338-D702386A2C71Q35142413-D0ACA3ED-EB89-4D8A-8060-960873763254Q35142978-0B3D0A5B-9F20-49CC-80D3-2F0BA64392FCQ36009235-7C8B4604-3A08-4E82-84D7-C31EB78018F5Q36188228-8488AFD3-881E-4422-9FE1-9E86604993E3Q36588920-8F9EF3D7-EE1B-4F57-89E1-50698DABB269Q37329252-1070766A-034E-48CD-A949-49431148EFDEQ37530267-E3CD4B65-B53F-4314-911C-62679BAC2FB1Q37660290-80F86DAF-0CBF-4833-9148-3B109164DA10Q37825724-1CAC47D8-7A0D-4B22-82DF-A1B9DCB96635Q37833424-B416E38D-500D-45BD-9D8B-911CD9A245E7Q38776694-C877E39A-1611-4340-82F6-D609A819B17EQ38965179-4C314373-68FC-44D4-8115-4FF2E9D9EBEDQ39323969-3254BEBE-FF72-4C9C-92F5-71C47D2E1191Q39665148-160BCA82-04A4-44A4-8BC3-F70655727E2BQ39931378-4416CAC7-BFB7-4D8E-8678-D16FB86A1A6FQ39986947-D4255F72-90B7-41DE-BFF8-B68AA1B0BD69Q42368968-EBE51067-9ED3-4179-A4A8-F14E2C597395Q47275485-F3288B87-CDA6-49BD-A284-C65C55DB2D83Q48252141-D0BEF214-1F63-473B-BD40-9D65A87456F0
P2860
c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
c-Myc-induced chemosensitizati ...... ty in pancreatic cancer cells.
@en
type
label
c-Myc-induced chemosensitizati ...... ty in pancreatic cancer cells.
@en
prefLabel
c-Myc-induced chemosensitizati ...... ty in pancreatic cancer cells.
@en
P2093
P1476
c-Myc-induced chemosensitizati ...... ty in pancreatic cancer cells.
@en
P2093
Aliccia Bollig
Archana Thakur
Fakhara Ahmed
Fazlul H Sarkar
Hector Biliran
Jiusheng Wu
Joshua D Liao
Sanjeev Banerjee
P304
P356
10.1158/1078-0432.CCR-06-1844
P407
P577
2007-05-01T00:00:00Z